634 related articles for article (PubMed ID: 32106613)
1. Potential Applications of NRF2 Modulators in Cancer Therapy.
Panieri E; Buha A; Telkoparan-Akillilar P; Cevik D; Kouretas D; Veskoukis A; Skaperda Z; Tsatsakis A; Wallace D; Suzen S; Saso L
Antioxidants (Basel); 2020 Feb; 9(3):. PubMed ID: 32106613
[TBL] [Abstract][Full Text] [Related]
2. The Keap1-Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases.
Deshmukh P; Unni S; Krishnappa G; Padmanabhan B
Biophys Rev; 2017 Feb; 9(1):41-56. PubMed ID: 28510041
[TBL] [Abstract][Full Text] [Related]
3. Age-related cataracts: Role of unfolded protein response, Ca
Periyasamy P; Shinohara T
Prog Retin Eye Res; 2017 Sep; 60():1-19. PubMed ID: 28864287
[TBL] [Abstract][Full Text] [Related]
4. Contradictory roles of Nrf2/Keap1 signaling pathway in cancer prevention/promotion and chemoresistance.
Jeddi F; Soozangar N; Sadeghi MR; Somi MH; Samadi N
DNA Repair (Amst); 2017 Jun; 54():13-21. PubMed ID: 28415030
[TBL] [Abstract][Full Text] [Related]
5. The Keap1-Nrf2 system in cancers: stress response and anabolic metabolism.
Mitsuishi Y; Motohashi H; Yamamoto M
Front Oncol; 2012; 2():200. PubMed ID: 23272301
[TBL] [Abstract][Full Text] [Related]
6. Nrf2 Modulation in Breast Cancer.
Ghareghomi S; Habibi-Rezaei M; Arese M; Saso L; Moosavi-Movahedi AA
Biomedicines; 2022 Oct; 10(10):. PubMed ID: 36289931
[TBL] [Abstract][Full Text] [Related]
7. Discovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction as potential therapeutic and preventive agents.
Abed DA; Goldstein M; Albanyan H; Jin H; Hu L
Acta Pharm Sin B; 2015 Jul; 5(4):285-99. PubMed ID: 26579458
[TBL] [Abstract][Full Text] [Related]
8. Cancer Cell Growth Is Differentially Affected by Constitutive Activation of NRF2 by KEAP1 Deletion and Pharmacological Activation of NRF2 by the Synthetic Triterpenoid, RTA 405.
Probst BL; McCauley L; Trevino I; Wigley WC; Ferguson DA
PLoS One; 2015; 10(8):e0135257. PubMed ID: 26301506
[TBL] [Abstract][Full Text] [Related]
9. Dual roles and therapeutic potential of Keap1-Nrf2 pathway in pancreatic cancer: a systematic review.
Qin JJ; Cheng XD; Zhang J; Zhang WD
Cell Commun Signal; 2019 Sep; 17(1):121. PubMed ID: 31511020
[TBL] [Abstract][Full Text] [Related]
10. Nrf2 in cancers: A double-edged sword.
Wu S; Lu H; Bai Y
Cancer Med; 2019 May; 8(5):2252-2267. PubMed ID: 30929309
[TBL] [Abstract][Full Text] [Related]
11. Keap1-Nrf2 pathway: A promising target towards lung cancer prevention and therapeutics.
Tong YH; Zhang B; Fan Y; Lin NM
Chronic Dis Transl Med; 2015 Sep; 1(3):175-186. PubMed ID: 29063005
[TBL] [Abstract][Full Text] [Related]
12. Insights into the New Cancer Therapy through Redox Homeostasis and Metabolic Shifts.
Hyun DH
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32645959
[TBL] [Abstract][Full Text] [Related]
13. Targeting nrf2 signaling to combat chemoresistance.
No JH; Kim YB; Song YS
J Cancer Prev; 2014 Jun; 19(2):111-7. PubMed ID: 25337579
[TBL] [Abstract][Full Text] [Related]
14. The potential roles of Nrf2/Keap1 signaling in anticancer drug interactions.
Wang J; Yang J; Cao M; Zhao Z; Cao B; Yu S
Curr Res Pharmacol Drug Discov; 2021; 2():100028. PubMed ID: 34909662
[TBL] [Abstract][Full Text] [Related]
15. Targeting the cell signaling pathway Keap1-Nrf2 as a therapeutic strategy for adenocarcinomas of the lung.
Zhang B; Ma Z; Tan B; Lin N
Expert Opin Ther Targets; 2019 Mar; 23(3):241-250. PubMed ID: 30556750
[TBL] [Abstract][Full Text] [Related]
16. Role of the Keap1-Nrf2 pathway in cancer.
Leinonen HM; Kansanen E; Pölönen P; Heinäniemi M; Levonen AL
Adv Cancer Res; 2014; 122():281-320. PubMed ID: 24974185
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of miR-200a protects cardiomyocytes against hypoxia-induced apoptosis by modulating the kelch-like ECH-associated protein 1-nuclear factor erythroid 2-related factor 2 signaling axis.
Sun X; Zuo H; Liu C; Yang Y
Int J Mol Med; 2016 Oct; 38(4):1303-11. PubMed ID: 27573160
[TBL] [Abstract][Full Text] [Related]
18. An Overview of the Advantages of KEAP1-NRF2 System Activation During Inflammatory Disease Treatment.
Keleku-Lukwete N; Suzuki M; Yamamoto M
Antioxid Redox Signal; 2018 Dec; 29(17):1746-1755. PubMed ID: 28899203
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution.
Taguchi K; Motohashi H; Yamamoto M
Genes Cells; 2011 Feb; 16(2):123-40. PubMed ID: 21251164
[TBL] [Abstract][Full Text] [Related]
20. Selenepezil, a Selenium-Containing Compound, Exerts Neuroprotective Effect via Modulation of the Keap1-Nrf2-ARE Pathway and Attenuates Aβ-Induced Cognitive Impairment in Vivo.
Yan J; Pang Y; Zhuang J; Lin H; Zhang Q; Han L; Ke P; Zhuang J; Huang X
ACS Chem Neurosci; 2019 Jun; 10(6):2903-2914. PubMed ID: 31035749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
